Correlation Between Inozyme Pharma and Amgen
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Amgen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Amgen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Amgen Inc, you can compare the effects of market volatilities on Inozyme Pharma and Amgen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Amgen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Amgen.
Diversification Opportunities for Inozyme Pharma and Amgen
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Inozyme and Amgen is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Amgen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amgen Inc and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Amgen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amgen Inc has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Amgen go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Amgen
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Amgen. In addition to that, Inozyme Pharma is 2.03 times more volatile than Amgen Inc. It trades about -0.22 of its total potential returns per unit of risk. Amgen Inc is currently generating about 0.22 per unit of volatility. If you would invest 28,655 in Amgen Inc on December 4, 2024 and sell it today you would earn a total of 2,613 from holding Amgen Inc or generate 9.12% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Inozyme Pharma vs. Amgen Inc
Performance |
Timeline |
Inozyme Pharma |
Amgen Inc |
Inozyme Pharma and Amgen Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Inozyme Pharma and Amgen
The main advantage of trading using opposite Inozyme Pharma and Amgen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Amgen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will offset losses from the drop in Amgen's long position.Inozyme Pharma vs. Beam Therapeutics | Inozyme Pharma vs. Editas Medicine | Inozyme Pharma vs. Caribou Biosciences | Inozyme Pharma vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Commodity Directory Find actively traded commodities issued by global exchanges |